Alpha-mannosidosis

Dag Malm1, Øivind Nilssen

  • 1Department of Gastroenterology, University Hospital of North Norway, NO-9038, Norway. dag.malm@unn.no

Insights

Alpha-mannosidosis is a rare inherited disorder causing immune deficiency, intellectual disability, and skeletal issues due to alpha-mannosidase deficiency. Early diagnosis and proactive management are crucial for improving patient outcomes and quality of life.

Area of Science:

  • Genetics and Genetic Disorders
  • Biochemistry
  • Lysosomal Storage Diseases

Background:

  • Alpha-mannosidosis is a rare autosomal recessive inherited lysosomal storage disorder.
  • It is caused by deficiency of the enzyme alpha-mannosidase, leading to accumulation of mannose-rich oligosaccharides.
  • The condition presents with a wide spectrum of clinical manifestations, including immune deficiency, skeletal abnormalities, hearing impairment, and intellectual disability.

Purpose of the Study:

  • To provide a comprehensive overview of Alpha-mannosidosis.
  • To highlight the genetic basis, clinical features, diagnostic approaches, and management strategies.
  • To emphasize the importance of early intervention and genetic counseling.

Main Methods:

  • Literature review of existing studies and clinical data on Alpha-mannosidosis.
  • Analysis of diagnostic criteria, including biochemical assays and genetic testing.
  • Review of current management protocols and long-term prognosis.

Main Results:

  • Alpha-mannosidosis affects approximately 1 in 500,000 live births, with significant clinical variability.
  • Key features include recurrent infections, dysostosis multiplex, sensorineural hearing loss, and progressive cognitive and motor decline.
  • Diagnosis relies on measuring alpha-mannosidase activity and genetic confirmation via mutations in the MAN2B1 gene.

Conclusions:

  • Alpha-mannosidosis is a severe lysosomal storage disorder with a poor long-term prognosis, often leading to wheelchair dependency and limited social independence.
  • Proactive management, including infection treatment, supportive therapies, and early educational intervention, is essential.
  • Genetic counseling and antenatal diagnosis are vital for affected families.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...